Xtant Medical Holdings Analyst Price Targets - Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD82,907.00+0.42%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Xtant Medical Holdings Inc

XTNTAMEX

Trade with Public

Trade with Public

$0.3205

-0.0005-0.16%

Last update: Oct 9, 4:00 PM

$0.3298

0.00882.74%

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Xtant Medical Holdings Analyst Price Targets - Benzinga

Xtant Medical Holdings Analyst Price Targets

Wall Street analyst price targets and consensus rating for Xtant Medical Holdings (XTNT).

Price Target Range — 6 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingBuy# Analysts2Avg. Consensus PT$1Upside to Avg. PT+212.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 2, 2026	LUCID CAPITAL MARKETS	Alex Nowark	Initiate	Buy	$1
May 13, 2026	BTIG	Ryan Zimmerman	Maintained	Buy	$1
Mar 31, 2026	BTIG	Ryan Zimmerman	PT Cut	Buy	$2→$1
Nov 11, 2025	BTIG	Ryan Zimmerman	PT Cut	Buy	$2→$2
May 16, 2024	BTIG	Ryan Zimmerman	PT Raise	Buy	$2→$3
Dec 5, 2023	BTIG	Ryan Zimmerman	Initiate	Buy	$2

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Xtant Medical Holdings with Buy Rating, Announces Price Target of $1

LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Xtant Medical Holdings (AMEX:XTNT) with a Buy rating and announces Price Target of $1.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Xtant Medical Holdings, Maintains $1 Price Target

BTIG analyst Ryan Zimmerman reiterates Xtant Medical Holdings (AMEX:XTNT) with a Buy and maintains $1 price target.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Xtant Medical Hldgs, Lowers Price Target to $1

BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and lowers the price target from $1.5 to $1.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Xtant Medical Hldgs, Lowers Price Target to $1.5

BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and lowers the price target from $2 to $1.5.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Xtant Medical Hldgs, Raises Price Target to $3

BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and raises the price target from $2 to $3.

Benzinga Newsdesk

PRO
BTIG Initiates Coverage On Xtant Medical Hldgs with Buy Rating, Announces Price Target of $2

BTIG analyst Ryan Zimmerman initiates coverage on Xtant Medical Hldgs (AMEX:XTNT) with a Buy rating and announces Price Target of $2.

Benzinga Newsdesk